Simon Quick Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-481
Closed -$307K 412
2025
Q3
$307K Sell
481
-141
-23% -$85.6K 0.01% 323
2025
Q2
$334K Sell
622
-235
-27% -$112K 0.02% 291
2025
Q1
$360K Buy
+857
New +$372K 0.02% 380
2024
Q4
Sell
-543
Closed -$274K 499
2024
Q3
$274K Sell
543
-54
-9% -$26.2K 0.02% 342
2024
Q2
$291K Sell
597
-38
-6% -$19.1K 0.02% 292
2024
Q1
$343K Sell
635
-82
-11% -$44.8K 0.03% 262
2023
Q4
$398K Buy
717
+13
+2% +$6.1K 0.04% 199
2023
Q3
$308K Buy
704
+141
+25% +$70.3K 0.03% 231
2023
Q2
$283K Sell
563
-70
-11% -$33.5K 0.03% 212
2023
Q1
$317K Buy
633
+110
+21% +$52.6K 0.03% 198
2022
Q4
$213K Buy
+523
New +$203K 0.03% 217

Other funds holding IDXX

Simon Quick Advisors's IDXX Position: Q4 2025 in Review

Simon Quick Advisors sold out of Idexx Laboratories (IDXX) in Q4 2025, closing a stake of 481 shares — an estimated $307K sold.

Simon Quick Advisors first reported a position in IDXX in Q4 2022 and held it in 11 quarters. The position peaked at $398K in Q4 2023. 1,386 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

  • Simon Quick Advisors reported no remaining Idexx Laboratories position as of Q4 2025 after selling out during the quarter.
  • Simon Quick Advisors sold 481 Idexx Laboratories shares in Q4 2025, an estimated $307K.
  • Simon Quick Advisors first reported a position in Idexx Laboratories in Q4 2022 and held it in 11 quarters.
  • Simon Quick Advisors's Idexx Laboratories position peaked at $398K in Q4 2023.
  • 1,386 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on Simon Quick Advisors's 13F filing for Q4 2025, filed 29 Jan 2026.